CIK 0001576885 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -121.3 M | -52.4 M | -42.9 M |
| Diluted EPS (USD/shares) | -2 | -1.08 | -1.06 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-16 | 8-K | 8-K items 7.01,9.01 | 2026-09-16 |
| 2026-08-12 | S-8 | S-8 | |
| 2026-08-12 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-12 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-08-12 |
| 2026-06-17 | 4 | FORM 4 | 2026-06-15 |
| 2026-06-17 | 144 | 144 | |
| 2026-06-16 | 144 | 144 | |
| 2026-06-16 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-06-12 |
| 2026-06-15 | 144 | 144 | |
| 2026-06-10 | 4 | FORM 4 | 2026-06-09 |
| 2026-06-09 | 144 | 144 | |
| 2026-06-05 | 4 | 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-05 | 4 | FORM 4 | 2026-06-03 |
| 2026-06-03 | 8-K | 8-K items 5.07 | 2026-06-03 |
| 2026-05-12 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-12 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-05-12 |
| 2026-04-23 | ARS | ARS | 2025-12-31 |
| 2026-04-23 | DEFA14A | DEFA14A | |
| 2026-04-23 | DEF 14A | DEF 14A | 2025-12-31 |
Forms on file (last 1,000): 4 120, 144 61, 8-K 54, 3 19, 10-Q 16, CORRESP 8, S-8 7, SC 13G 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ABOS (0.002 USD), /gw/filings/filings?ticker=ABOS&form=8-K, /gw/filings/facts?ticker=ABOS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange